References
- Braue EH, Jr, Smith KH, Doxzon BF, et al. Efficacy studies of reactive skin decontamination lotion, M291 skin decontamination kit, 0.5% bleach, 1% soapy water, and skin exposure reduction paste against chemical warfare agents, part 1: guinea pigs challenged with VX. Cutan Ocul Toxicol 2011;30:15–28.
- Walters TJ, Kauvar DS, Reeder J, et al. Effect of reactive skin decontamination lotion on skin wound healing in laboratory rats. Mil Med 2007;172:318–321.
- Fentabil M, Gebremedhin M, Purdon JG, et al. Degradation of pesticides with RSDL® (reactive skin decontamination lotion kit) lotion: LC-MS investigation. Toxicol Lett 2018;293:241–248.
- U.S. Food and Drug Administration: Emergency Preparedness Drugs [Internet]. Products approved for chemical emergencies; FDA clears skin lotion for military to protect against chemical burns; 2003 March 28. Available from: https://www.fda.gov/drugs/bioterrorism-and-drug-preparedness/fda-clears-skin-lotion-military-protect-against-chemical-burns
- Schwartz MD, Hurst CG, Kirk MA, et al. Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure. Curr Pharm Biotechnol 2012;13:1971–1979.
- Medical Management of Chemical Casualties Handbook. Fifth Edition. Aberdeen Proving Ground: US Army Medical Research Institute of Chemical Defense; 2014.
- Thors L, Lindberg S, Johansson S, et al. RSDL decontamination of human skin contaminated with the nerve agent VX. Toxicol Lett 2017;269:47–54.
- Braue EH, Jr, Smith KH, Doxzon BF, et al. Efficacy studies of reactive skin decontamination lotion, M291 skin decontamination kit, 0.5% bleach, 1% soapy water, and skin exposure reduction paste against chemical warfare agents, part 2: guinea pigs challenged with soman. Cutan Ocul Toxicol 2011;30:29–37.
- U.S. Department of Health & Human Services. Chemical hazards emergency medical management; medical countermeasures database; reactive skin decontamination lotion; 2017 Sep 03. Available from: https://chemm.nlm.nih.gov/countermeasure_RSDL.htm
- Bogan R, Maas HJ, Zimmermann T. Chemical stability of reactive skin decontamination lotion (RSDL®). Toxicol Lett 2018;293:264–268.
- Koplovitz I, Schulz S, Morgan J, et al. Comparison of four skin decontamination procedures using reactive skin decontamination lotion (RSDL) following cutaneous VX exposure in guinea pigs. USAMRICD-TR-17-01. Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense; January 2016.
- Taysee L, Daulon S, Delamanche S, et al. Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller’s earth in domestic swine. Hum Exp Toxicol 2007;26:135–141.
- Bjarnason S, Mikler J, Hill I, et al. Comparison of selected skin decontamination products and regimens against VX in domestic swine. Hum Exp Toxicol 2008;27:253–261.
- Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009;37:1528–1542.
- Dorsett-Martin WA. Rat models of skin wound healing: a review. Wound Repair Regen 2004;12:591–599.
- Davidson JM. Animal models for wound repair. Arch Dermatol Res 1998;290:S1–S11.
- Wong VW, Sorkin M, Glotzbach JP, et al. Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol 2010;2011;969618.
- Seaton M, Hocking A, Gibran NS. Porcine models of cutaneous wound healing. ILAR J 2015;56:127–138.
- Perez R, Davis SC. Relevance of animal models for wound healing. Wounds 2008;20:3–8.
- Swinde MM, Smith AC. Swine in the laboratory. 3rd ed. Boca Raton, FL: CRC Press Taylor and Francis Group; 2016.
- Graham JS, Schomacker KT, Glatter RD, et al. Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res Technol 2002;8:57–69.
- Serup J, Jemec GBE, Grove GL. editors. Handbook of non-invasive methods and the skin. 2nd ed. Boca Raton, FL: CRC Press Taylor and Francis Group; 2006.
- Alexander H, Brown S, Danby S, et al. Research techniques made simple: transepidermal water loss measurement as a research tool. J Invest Dermatol 2018;138:2295–2300.
- Singer AJ, Thode HC Jr, McClain SA. Development of a histomorphologic scale to quantify cutaneous scars after burns. Acad Emerg Med 2000;7:1083–1088.
- Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738–746.
- 2nd BG, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg 2006;117:12S–34S.
- Azzimonti B, Sabbatini M, Rimondini L, et al. Part One, Section 4, Manipulating the healing response. In: Wound healing biomaterials – volume 1: therapies and regeneration. Duxford, UK: Woodhead Publishing Elsevier; 2016; p. 101–10.
- Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010;89:219–229.
- Monaco JL, Lawrence WT. Acute wound healing an overview. Clin Plast Surg 2003;30:1–12.
- Junker JPE, Kamel RA, Caterson EJ, et al. Clinical impact upon wound healing and inflammation in moist, wet, and dry environments. Adv Wound Care 2013;2:348–356.
- Barillo DJ, Barillo AR, Korn S, et al. The antimicrobial spectrum of Xeroform®. Burns 2017;43:1189–1194.
- 3M ScienceTM. Health care, skin and wound care; 2019. Available from: https://www.3m.com/3M/en_US/company-us/all-3m-products/∼/All-3M-Products/Health-Care/Medical/Skin-Wound-Care/Tegaderm/?N=5002385+8707795+8707798+8711017+8711098+8711738+3294857497&rt=r3